Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of humoral and cellular response to third dose of BNT162b2 mRNA COVID-19 vaccine in patients treated with B-cell depleting therapy.
Firinu D, Fenu G, Sanna G, Costanzo GA, Perra A, Campagna M, Littera R, Locci C, Marongiu A, Cappai R, Melis M, Orrù G, Del Giacco S, Coghe F, Manzin A, Chessa L. Firinu D, et al. Among authors: del giacco s. J Autoimmun. 2022 Jul;131:102848. doi: 10.1016/j.jaut.2022.102848. Epub 2022 Jun 13. J Autoimmun. 2022. PMID: 35714496 Free PMC article.
Biological treatments for SAPHO syndrome: an update.
Firinu D, Murgia G, Lorrai MM, Barca MP, Peralta MM, Manconi PE, del Giacco SR. Firinu D, et al. Inflamm Allergy Drug Targets. 2014;13(3):199-205. doi: 10.2174/1871528113666140520100402. Inflamm Allergy Drug Targets. 2014. PMID: 24846337 Review.
Biologics for ANCA-associated vasculitis.
Murgia G, Firinu D, Manconi PE, Del Giacco SR. Murgia G, et al. Inflamm Allergy Drug Targets. 2014;13(4):275-87. doi: 10.2174/1871528113666140702094456. Inflamm Allergy Drug Targets. 2014. PMID: 24998311
208 results